> WuXi PharmaTech ($WX) signed a deal to work with Gilead Sciences ($GILD) on R&D in its native China. News
> CRO PharPoint Research expanded its North Carolina headquarters to account for "stable growth of new employees," the company said. More
> WuXi PharmaTech ($WX) signed a deal to work with Gilead Sciences ($GILD) on R&D in its native China. News
> CRO PharPoint Research expanded its North Carolina headquarters to account for "stable growth of new employees," the company said. More